What is The Vita Coco Company, Inc.'s earnings per share (EPS)?

The Vita Coco Company, Inc. (COCO) reported diluted earnings per share of $1.19 for fiscal year 2025. This represents a 26.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

The Vita Coco Company, Inc. (COCO) Financials

COCO

Trailing 12 months to June 30, 2026

Revenue $706.0M +26.1% YoY

Net Income $110.8M +72.0% YoY

EPS (Diluted) $1.81 +70.8% YoY

Free Cash Flow $124.4M +375.2% YoY

Market Cap $3.3B as of Oct 14, 2026

Price / Sales 4.7x on $706.0M revenue, trailing 12 months to June 30, 2026

Price / Earnings 30.1x on $110.8M net income, trailing 12 months to June 30, 2026

Price / Book 8.3x on $400.9M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 23, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the COCO SEC filings page.

The Vita Coco Company, Inc. (COCO) reported $706.0M in revenue over the twelve months to Jun 30, 2026, up 26.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI COCO FY2025 2026-10-03

The business has become more profitable at scale, but FY2025 growth absorbed working capital and converted less profit into cash.

FY2025 net income reached $72.7M while operating cash flow was $47.2M, so accounting earnings did not translate fully into cash. Free cash flow slipped from $41.9M to $39.0M as inventory and receivables expanded, indicating growth consumed more working capital even while margins stayed high.

The margin step-up beginning in FY2023 persisted through FY2025, with operating margin staying above 13%; this suggests scale and/or mix improved the economics, though FY2025 gave back some gross-margin gains.

The balance sheet remained liquid and lightly levered, with a 3.6x current ratio and 0.4x debt-to-equity ratio in FY2025. That posture gives the company flexibility to fund rising inventory and receivables without relying heavily on debt.

Financial Health Signals

Financial Health Score 72/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of The Vita Coco Company, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

The Vita Coco Company, Inc. has an operating margin of 13.5%, meaning the company retains $14 of operating profit per $100 of revenue. This strong profitability earns a score of 68/100, reflecting efficient cost management and pricing power. This is down from 14.3% the prior year.

Growth

The Vita Coco Company, Inc.'s revenue surged 18.2% year-over-year to $609.8M, reflecting rapid business expansion. This strong growth earns a score of 68/100.

Leverage

The Vita Coco Company, Inc. carries a low D/E ratio of 0.39, meaning only $0.39 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 65/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.62, The Vita Coco Company, Inc. holds $3.62 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.

Cash Flow

The Vita Coco Company, Inc. converts 6.4% of revenue into free cash flow ($39.0M). This strong cash generation earns a score of 65/100.

Returns

The Vita Coco Company, Inc. earns a strong 21.9% return on equity (ROE), meaning it generates $22 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 83/100. This is up from 21.6% the prior year.

Altman Z-Score Safe

18.83

The Vita Coco Company, Inc. scores 18.83, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.3B) relative to total liabilities ($129.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/8

The Vita Coco Company, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

0.65x

For every $1 of reported earnings, The Vita Coco Company, Inc. generates $0.65 in operating cash flow ($47.2M OCF vs $72.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$216.2M

YoY+28.1%

QoQ+20.2%

5Y CAGR+16.3%

The Vita Coco Company, Inc. generated $216.2M in revenue in Q2 2026. This represents an increase of 28.1% from the same quarter a year earlier. Against the prior quarter it is up 20.2%.

EBITDA

$63.6M

YoY+151.2%

QoQ+86.8%

5Y CAGR+51.2%

The Vita Coco Company, Inc.'s EBITDA was $63.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 151.2% from the same quarter a year earlier. Against the prior quarter it is up 86.8%.

Net Income

$49.5M

YoY+115.9%

QoQ+62.3%

5Y CAGR+44.7%

The Vita Coco Company, Inc. reported $49.5M in net income in Q2 2026. This represents an increase of 115.9% from the same quarter a year earlier. Against the prior quarter it is up 62.3%.

EPS (Diluted)

$0.82

YoY+115.8%

QoQ+64.0%

5Y CAGR+40.5%

The Vita Coco Company, Inc. earned $0.82 per diluted share (EPS) in Q2 2026. This represents an increase of 115.8% from the same quarter a year earlier. Against the prior quarter it is up 64.0%.

Cash & Balance Sheet

Free Cash Flow

$80.8M

YoY+287.2%

QoQ+433.6%

5Y CAGR+358.2%

The Vita Coco Company, Inc. generated $80.8M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 287.2% from the same quarter a year earlier. Against the prior quarter it is up 433.6%.

Cash & Debt

$278.6M

YoY+66.8%

QoQ+38.0%

5Y CAGR+70.2%

The Vita Coco Company, Inc. held $278.6M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

57M

YoY+1.0%

QoQ+0.5%

The Vita Coco Company, Inc. had 57M shares outstanding in Q2 2026. This represents an increase of 1.0% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

48.7%

YoY+12.4pp

QoQ+8.8pp

5Y change+20.3pp

The Vita Coco Company, Inc.'s gross margin was 48.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 12.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.8 percentage points.

Operating Margin

29.2%

YoY+14.3pp

QoQ+10.5pp

5Y change+21.8pp

The Vita Coco Company, Inc.'s operating margin was 29.2% in Q2 2026, reflecting core business profitability. This is up 14.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.5 percentage points.

Net Margin

22.9%

YoY+9.3pp

QoQ+5.9pp

5Y change+15.2pp

The Vita Coco Company, Inc.'s net profit margin was 22.9% in Q2 2026, showing the share of revenue converted to profit. This is up 9.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.9 percentage points.

Return on Equity

12.3%

YoY+4.6pp

QoQ+3.7pp

5Y change0.0pp

The Vita Coco Company, Inc.'s ROE was 12.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 4.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.7 percentage points.

Capital Allocation

Share Buybacks

$8.5M

YoY-0.6%

QoQ-26.1%

The Vita Coco Company, Inc. spent $8.5M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 0.6% from the same quarter a year earlier. Against the prior quarter it is down 26.1%.

Capital Expenditures

$151K

YoY-84.1%

QoQ-67.2%

5Y CAGR+39.1%

The Vita Coco Company, Inc. invested $151K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 84.1% from the same quarter a year earlier. Against the prior quarter it is down 67.2%.

R&D Spending

Not reported for Q2 2026.

COCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

COCO quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Revenue	$706.0M	$609.8M+18.2%	$516.0M+4.5%	$493.6M+15.4%	$427.8M+12.7%	$379.5M+22.2%	$310.6M+9.4%	$283.9M
Cost of Revenue	$415.6M	$387.2M+22.1%	$317.2M+1.4%	$312.9M-3.6%	$324.4M+21.8%	$266.4M+29.4%	$205.8M+7.8%	$191.0M
Gross Profit	$290.4M	$222.6M+12.0%	$198.8M+10.0%	$180.7M+74.9%	$103.4M-8.6%	$113.1M+7.9%	$104.9M+12.8%	$93.0M
R&D Expenses	N/A	$399K+0.3%	$398K-4.8%	$418K-22.7%	$541K+13.4%	$477K+52.4%	$313K-51.2%	$642K
SG&A Expenses	$155.5M	$140.1M+12.1%	$125.0M+0.6%	$124.2M+23.9%	$100.3M+13.3%	$88.6M+19.0%	$74.4M-5.7%	$78.9M
Operating Income	$134.8M	$82.5M+11.8%	$73.8M+30.7%	$56.5M+1749.2%	$3.1M-87.6%	$24.6M-47.5%	$46.9M+250.4%	$13.4M
EBITDA	N/A	$83.6M+12.1%	$74.6M+30.5%	$57.2M+1053.2%	$5.0M-81.4%	$26.7M-45.6%	$49.0M+217.0%	$15.5M
Interest Expense	N/A	N/A	$0-100.0%	$31K-88.0%	$258K-28.3%	$360K-54.5%	$791K-32.0%	$1.2M
Income Tax	$32.8M	$21.7M+45.9%	$14.8M+31.4%	$11.3M+273.0%	$3.0M-42.2%	$5.2M-52.0%	$10.9M+451.4%	$2.0M
Net Income	$110.8M	$72.7M+29.9%	$56.0M+20.0%	$46.6M+496.7%	$7.8M-58.9%	$19.0M-41.8%	$32.7M+246.8%	$9.4M
EPS (Basic)	N/A	$1.25+26.3%	$0.99+19.3%	$0.83+492.9%	$0.14-60.0%	$0.35-37.5%	$0.56+229.4%	$0.17
EPS (Diluted)	$1.81	$1.19+26.6%	$0.94+19.0%	$0.79+464.3%	$0.14-60.0%	$0.35-37.5%	$0.56+250.0%	$0.16
Diluted Shares (Avg)	N/A	60M+1.1%	59M+0.9%	59M+4.7%	56M+3.6%	54M-7.5%	59M+2.6%	57M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$216.2M+28.1%	$179.8M+37.3%	$127.8M+0.4%	$182.3M+37.2%	$168.8M+17.1%	$130.9M+17.2%	$127.3M+19.9%	$132.9M-3.7%
Cost of Revenue	$110.8M+3.1%	$108.0M+30.3%	$83.2M-3.2%	$113.6M+39.7%	$107.5M+25.9%	$82.8M+28.4%	$86.0M+29.6%	$81.3M-0.7%
Gross Profit	$105.3M+71.9%	$71.8M+49.3%	$44.6M+7.9%	$68.7M+33.2%	$61.3M+4.3%	$48.1M+1.9%	$41.3M+3.8%	$51.6M-8.2%
SG&A Expenses	$42.2M+16.7%	$38.2M+32.8%	$34.4M-7.1%	$40.7M+31.6%	$36.1M+25.7%	$28.8M+2.0%	$37.0M+7.7%	$31.0M-5.2%
Operating Income	$63.1M+151.3%	$33.6M+74.1%	$10.2M+137.9%	$27.9M+35.6%	$25.1M-16.2%	$19.3M+1.8%	$4.3M-21.0%	$20.6M-12.4%
EBITDA	$63.6M+151.2%	$34.1M+74.7%	$10.6M+136.7%	$28.2M+35.4%	$25.3M-16.0%	$19.5M+2.0%	$4.5M-19.5%	$20.8M-12.2%
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%
Income Tax	$14.9M+183.2%	$7.0M+27.1%	$4.2M+346.1%	$6.7M+4.9%	$5.3M-18.0%	$5.5M+45.1%	-$1.7M-244.5%	$6.4M+58.6%
Net Income	$49.5M+115.9%	$30.5M+61.4%	$6.9M+104.2%	$24.0M+24.7%	$22.9M+20.0%	$18.9M+32.6%	$3.4M-50.3%	$19.3M+27.0%
EPS (Basic)	$0.86+115.0%	$0.53+60.6%	$0.09+50.0%	$0.42+23.5%	$0.40+17.6%	$0.33+32.0%	$0.06-50.0%	$0.34+25.9%
EPS (Diluted)	$0.82+115.8%	$0.50+61.3%	$0.09+80.0%	$0.40+25.0%	$0.38+18.8%	$0.31+29.2%	$0.05-54.5%	$0.32+23.1%
Diluted Shares (Avg)	61M+1.7%	60M+0.8%	N/A	60M+1.0%	60M+0.7%	60M+2.1%	N/A	59M+0.1%

Not reported in any period shown, so not listed: R&D Expenses.

COCO Balance Sheet

COCO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Total Assets	$461.2M+27.3%	$362.4M+26.8%	$285.7M+44.5%	$197.8M+0.1%	$197.5M+7.4%	$183.9M	N/A
Current Assets	$421.4M+23.5%	$341.3M+29.8%	$262.9M+50.3%	$174.9M+1.0%	$173.3M+8.9%	$159.1M	N/A
Cash & Equivalents	$196.9M+19.6%	$164.7M+24.2%	$132.5M+575.2%	$19.6M-31.6%	$28.7M-60.3%	$72.2M+96.5%	$36.7M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0
Inventory	$111.5M+33.3%	$83.6M+64.7%	$50.8M-39.7%	$84.1M+11.6%	$75.4M+135.7%	$32.0M	N/A
Accounts Receivable	$81.5M+28.5%	$63.5M+26.7%	$50.1M+15.5%	$43.4M-8.1%	$47.2M+54.7%	$30.5M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0
Goodwill	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M	N/A
Total Liabilities	$129.6M+25.2%	$103.6M+24.4%	$83.2M+46.9%	$56.7M-23.7%	$74.3M-8.9%	$81.6M	N/A
Current Liabilities	$116.4M+12.7%	$103.3M+25.0%	$82.6M+52.0%	$54.3M-26.5%	$74.0M+32.8%	$55.7M	N/A
Non-Current Liabilities	$13.2M+4324.2%	$298K-54.8%	$660K-71.5%	$2.3M+564.2%	$349K-98.7%	$25.9M	N/A
Total Equity	$331.5M+28.1%	$258.8M+27.9%	$202.4M+43.5%	$141.1M+14.5%	$123.2M+20.5%	$102.2M+38.5%	$73.8M
Retained Earnings	$228.0M+45.5%	$156.7M+55.5%	$100.7M+82.6%	$55.2M+16.5%	$47.4M+67.1%	$28.4M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$572.9M+36.1%	$488.3M+27.2%	$461.2M+27.3%	$461.3M+30.6%	$421.1M+30.3%	$384.0M+32.8%	$362.4M+26.8%	$353.1M+31.5%
Current Assets	$535.0M+38.3%	$449.7M+27.9%	$421.4M+23.5%	$423.3M+28.0%	$386.7M+28.6%	$351.5M+31.8%	$341.3M+29.8%	$330.8M+33.7%
Cash & Equivalents	$278.6M+66.8%	$201.9M+31.4%	$196.9M+19.6%	$203.7M+30.0%	$167.0M+11.3%	$153.6M+24.9%	$164.7M+24.2%	$156.7M+65.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$82.9M-1.4%	$86.4M-2.2%	$111.5M+33.3%	$84.4M+30.1%	$84.1M+85.0%	$88.3M+55.6%	$83.6M+64.7%	$64.9M+28.8%
Accounts Receivable	$132.3M+29.0%	$120.8M+57.4%	$81.5M+28.5%	$103.4M+31.5%	$102.6M+30.0%	$76.8M+32.6%	$63.5M+26.7%	$78.6M-1.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%	$7.8M0.0%
Total Liabilities	$172.0M+38.6%	$136.2M+28.3%	$129.6M+25.2%	$137.6M+36.2%	$124.1M+36.4%	$106.1M+33.7%	$103.6M+24.4%	$101.0M+33.1%
Current Liabilities	$159.4M+44.9%	$123.2M+31.9%	$116.4M+12.7%	$123.5M+22.6%	$110.0M+21.2%	$93.4M+18.2%	$103.3M+25.0%	$100.7M+36.0%
Non-Current Liabilities	$12.6M-10.5%	$13.0M+2.1%	$13.2M+4324.2%	$14.1M+4266.6%	$14.1M+6425.5%	$12.7M+3541.7%	$298K-54.8%	$323K-82.4%
Total Equity	$400.9M+35.0%	$352.2M+26.7%	$331.5M+28.1%	$323.7M+28.4%	$296.9M+28.0%	$277.9M+32.5%	$258.8M+27.9%	$252.1M+30.9%
Retained Earnings	$307.9M+55.1%	$258.5M+47.2%	$228.0M+45.5%	$222.5M+45.1%	$198.5M+48.0%	$175.6M+52.7%	$156.7M+55.5%	$153.3M+63.2%

Not reported in any period shown, so not listed: Long-Term Debt.

COCO Cash Flow Statement

COCO quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Operating Cash Flow	$131.7M	$47.2M+10.0%	$42.9M-60.0%	$107.2M+1079.9%	-$10.9M+32.4%	-$16.2M-148.5%	$33.3M+53.1%	$21.8M
Depreciation & Amortization	N/A	$1.1M+43.9%	$745K+12.9%	$660K-65.3%	$1.9M-8.1%	$2.1M-2.6%	$2.1M+2.1%	$2.1M
Stock-Based Compensation	N/A	$10.8M+21.5%	$8.9M-2.3%	$9.1M+23.6%	$7.4M+118.5%	$3.4M+122.8%	$1.5M-31.9%	$2.2M
Capital Expenditures	$7.3M	$8.1M+736.7%	$974K+62.6%	$599K-39.0%	$982K+76.3%	$557K+42.1%	$392K-61.1%	$1.0M
Free Cash Flow	$124.4M	$39.0M-6.9%	$41.9M-60.7%	$106.6M+994.2%	-$11.9M+28.7%	-$16.7M-150.8%	$32.9M+58.7%	$20.8M
Investing Cash Flow	-$7.4M	-$8.3M-747.3%	-$974K-64.0%	-$594K+39.5%	-$982K-76.3%	-$557K-48.5%	-$375K+62.8%	-$1.0M
Financing Cash Flow	-$12.4M	-$7.5M+9.2%	-$8.3M-231.9%	$6.3M+107.3%	$3.0M+111.3%	-$26.8M-1407.5%	$2.0M+119.8%	-$10.4M
Share Buybacks	$21.2M	$11.3M-6.3%	$12.0M+1456.3%	$773K	$0-100.0%	$50.0M+620.5%	$6.9M+18656.8%	$37K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$80.9M+271.1%	$15.6M+259.2%	-$3.9M-156.3%	$39.1M+318.9%	$21.8M-19.0%	-$9.8M-3570.4%	$6.9M-81.4%	$9.3M-78.8%
Depreciation & Amortization	$489K+137.4%	$476K+135.6%	$436K+112.7%	$228K+16.3%	$206K+13.2%	$202K+24.7%	$205K+30.6%	$196K+20.2%
Stock-Based Compensation	$3.6M+21.2%	$4.6M+111.6%	N/A	$3.0M+39.0%	$3.0M+23.5%	$2.2M+3.7%	N/A	$2.1M-25.2%
Capital Expenditures	$151K-84.1%	$461K-17.5%	$3.2M+2482.4%	$3.4M+684.6%	$949K+227.2%	$559K+350.8%	$125K+89.4%	$435K+845.7%
Free Cash Flow	$80.8M+287.2%	$15.1M+246.1%	-$7.1M-204.8%	$35.6M+301.0%	$20.9M-21.7%	-$10.4M-2549.4%	$6.8M-81.7%	$8.9M-79.7%
Investing Cash Flow	-$151K+84.1%	-$461K+17.5%	-$3.3M-2565.6%	-$3.4M-684.6%	-$949K-227.2%	-$559K-350.8%	-$125K-89.4%	-$435K-845.7%
Financing Cash Flow	-$4.0M+49.9%	-$9.9M-801.0%	$397K-80.8%	$1.1M+163.8%	-$8.0M-1623.3%	-$1.1M+87.9%	$2.1M+426.2%	-$1.8M-156.5%
Share Buybacks	$8.5M-0.6%	$11.5M+666.5%	$1.1M	$151K-94.6%	$8.6M	$1.5M-83.7%	$0-100.0%	$2.8M

Not reported in any period shown, so not listed: Dividends Paid.

COCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

COCO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Gross Margin	36.5%-2.0pp	38.5%+1.9pp	36.6%+12.4pp	24.2%-5.6pp	29.8%-4.0pp	33.8%+1.0pp	32.8%
Operating Margin	13.5%-0.8pp	14.3%+2.9pp	11.4%+10.7pp	0.7%-5.8pp	6.5%-8.6pp	15.1%+10.4pp	4.7%
Net Margin	11.9%+1.1pp	10.8%+1.4pp	9.4%+7.6pp	1.8%-3.2pp	5.0%-5.5pp	10.5%+7.2pp	3.3%
Return on Equity	21.9%+0.3pp	21.6%-1.4pp	23.0%+17.5pp	5.5%-9.9pp	15.4%-16.5pp	31.9%+19.2pp	12.8%
Return on Assets	15.8%+0.3pp	15.4%-0.9pp	16.3%+12.4pp	4.0%-5.7pp	9.6%-8.1pp	17.8%	N/A
Current Ratio	3.62+0.3x	3.31+0.1x	3.180.0x	3.22+0.9x	2.34-0.5x	2.86	N/A
Debt-to-Equity	0.390.0x	0.400.0x	0.410.0x	0.40-0.2x	0.60-0.2x	0.80	N/A
Asset Turnover	1.32-0.1x	1.42-0.3x	1.73-0.4x	2.16+0.2x	1.92+0.2x	1.69	N/A
FCF Margin	6.4%-1.7pp	8.1%-13.5pp	21.6%+24.4pp	-2.8%+1.6pp	-4.4%-15.0pp	10.6%+3.3pp	7.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	48.7%+12.4pp	40.0%+3.2pp	34.9%+2.4pp	37.7%-1.1pp	36.3%-4.5pp	36.7%-5.5pp	32.5%-5.0pp	38.8%-1.9pp
Operating Margin	29.2%+14.3pp	18.7%+3.9pp	8.0%+4.6pp	15.3%-0.2pp	14.9%-5.9pp	14.7%-2.2pp	3.4%-1.7pp	15.5%-1.5pp
Net Margin	22.9%+9.3pp	17.0%+2.5pp	5.4%+2.7pp	13.2%-1.3pp	13.6%+0.3pp	14.4%+1.7pp	2.6%-3.7pp	14.5%+3.5pp
Return on Equity	12.3%+4.6pp	8.6%+1.8pp	2.1%+0.8pp	7.4%-0.2pp	7.7%-0.5pp	6.8%0.0pp	1.3%-2.1pp	7.6%-0.2pp
Return on Assets	8.6%+3.2pp	6.2%+1.3pp	1.5%+0.6pp	5.2%-0.3pp	5.4%-0.5pp	4.9%0.0pp	0.9%-1.4pp	5.5%-0.2pp
Current Ratio	3.36-0.2x	3.65-0.1x	3.62+0.3x	3.43+0.1x	3.51+0.2x	3.76+0.4x	3.31+0.1x	3.28-0.1x
Debt-to-Equity	0.430.0x	0.390.0x	0.390.0x	0.420.0x	0.420.0x	0.380.0x	0.400.0x	0.400.0x
Asset Turnover	0.380.0x	0.370.0x	0.28-0.1x	0.400.0x	0.400.0x	0.340.0x	0.350.0x	0.38-0.1x
FCF Margin	37.4%+25.0pp	8.4%+16.3pp	-5.6%-10.9pp	19.6%+12.9pp	12.4%-6.1pp	-7.9%-7.6pp	5.3%-29.6pp	6.7%-25.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
The Vita Coco Company, Inc. COCO	FY2025	$609.8M	$72.7M	11.9%	$3.3B	72/100
National Beverage Corp. FIZZ	FY2026	$1.2B	$183.6M	15.6%	$3.1B	73/100
Primo Brands Corporation PRMB	FY2025	$6.7B	$60.1M	0.9%	$6.8B	44/100
SunOpta, Inc. STKL	FY2026	$817.7M	$15.8M	1.9%	$769.4M	41/100
Coca-Cola Consolidated, Inc. COKE	FY2025	$7.2B	$570.6M	7.9%	$12.9B	56/100
Celsius Holdings, Inc. CELH	FY2025	$2.5B	$108.0M	4.3%	$7.1B	58/100

Where The Vita Coco Company, Inc. Ranks

Frequently Asked Questions

What is The Vita Coco Company, Inc.'s annual revenue?

The Vita Coco Company, Inc. (COCO) reported $609.8M in total revenue for fiscal year 2025. This represents a 18.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is The Vita Coco Company, Inc.'s revenue growing?

The Vita Coco Company, Inc. (COCO) revenue grew by 18.2% year-over-year, from $516.0M to $609.8M in fiscal year 2025.

Is The Vita Coco Company, Inc. profitable?

Yes, The Vita Coco Company, Inc. (COCO) reported a net income of $72.7M in fiscal year 2025, with a net profit margin of 11.9%.

What is The Vita Coco Company, Inc.'s EBITDA?

The Vita Coco Company, Inc. (COCO) had EBITDA of $83.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is The Vita Coco Company, Inc.'s gross margin?

The Vita Coco Company, Inc. (COCO) had a gross margin of 36.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is The Vita Coco Company, Inc.'s operating margin?

The Vita Coco Company, Inc. (COCO) had an operating margin of 13.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is The Vita Coco Company, Inc.'s net profit margin?

The Vita Coco Company, Inc. (COCO) had a net profit margin of 11.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is The Vita Coco Company, Inc.'s return on equity (ROE)?

The Vita Coco Company, Inc. (COCO) has a return on equity of 21.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is The Vita Coco Company, Inc.'s free cash flow?

The Vita Coco Company, Inc. (COCO) generated $39.0M in free cash flow during fiscal year 2025. This represents a -6.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is The Vita Coco Company, Inc.'s operating cash flow?

The Vita Coco Company, Inc. (COCO) generated $47.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are The Vita Coco Company, Inc.'s total assets?

The Vita Coco Company, Inc. (COCO) had $461.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are The Vita Coco Company, Inc.'s capital expenditures?

The Vita Coco Company, Inc. (COCO) invested $8.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does The Vita Coco Company, Inc. spend on research and development?

The Vita Coco Company, Inc. (COCO) invested $399K in research and development during fiscal year 2025.

Does The Vita Coco Company, Inc. buy back shares?

Yes, The Vita Coco Company, Inc. (COCO) spent $11.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does The Vita Coco Company, Inc. have outstanding?

The Vita Coco Company, Inc. (COCO) had 57M shares outstanding as of fiscal year 2025.

What is The Vita Coco Company, Inc.'s current ratio?

The Vita Coco Company, Inc. (COCO) had a current ratio of 3.62 as of fiscal year 2025, which is generally considered healthy.

What is The Vita Coco Company, Inc.'s debt-to-equity ratio?

The Vita Coco Company, Inc. (COCO) had a debt-to-equity ratio of 0.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is The Vita Coco Company, Inc.'s return on assets (ROA)?

The Vita Coco Company, Inc. (COCO) had a return on assets of 15.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is The Vita Coco Company, Inc.'s P/E ratio?

The Vita Coco Company, Inc. (COCO) trades at 30.1x earnings, its market capitalization divided by net income of $110.8M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.3B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is The Vita Coco Company, Inc.'s price-to-sales ratio?

The Vita Coco Company, Inc. (COCO) trades at 4.7x sales, its market capitalization divided by revenue of $706.0M revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.3B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is The Vita Coco Company, Inc.'s Altman Z-Score?

The Vita Coco Company, Inc. (COCO) has an Altman Z-Score of 18.83, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is The Vita Coco Company, Inc.'s Piotroski F-Score?

The Vita Coco Company, Inc. (COCO) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are The Vita Coco Company, Inc.'s earnings high quality?

The Vita Coco Company, Inc. (COCO) has an earnings quality ratio of 0.65x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is The Vita Coco Company, Inc.?

The Vita Coco Company, Inc. (COCO) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.